{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:03:12Z","timestamp":1785171792688,"version":"3.55.0"},"reference-count":119,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Inhalable ribonucleic acid (RNA) nanomedicines are emerging as versatile therapeutics for respiratory diseases and pulmonary metastases, enabling localized delivery of messenger RNA (mRNA), small interfering RNA (siRNA), antisense oligonucleotides, microRNA (miRNA) mimics, self-amplifying RNA, and genome-editing systems. This review synthesizes the available evidence and argues that the field has moved beyond asking whether RNA can reach the lungs. The more consequential translational question is whether RNA cargo, nanocarrier, excipients, manufacturing process, inhalation device, and pulmonary target cell can be integrated into a reproducible therapeutic product. Current research demonstrates progress in disease-corrective mRNA expression, silencing of inflammatory and fibrotic pathways, mucosal vaccination, antiviral therapy, and localized cancer treatment, alongside advances in ionizable lipid nanoparticles, lipid\u2013polymer hybrids, chitosan and polyethyleneimine (PEI) polyplexes, dendrimers, peptide carriers, biomimetic systems, and dry-powder formulations. Translational maturity, however, remains uneven. Many studies demonstrate carrier feasibility, reporter expression, or preclinical activity, whereas fewer establish device-compatible aerosolization, preservation of RNA integrity during processing, traversal of pulmonary barriers, target-cell engagement, repeat-dose tolerability, and clinically meaningful benefit. Development should therefore be target-defined, analytically gated, device-specific, and outcome-centered. Inhalable RNA nanomedicines are best understood as integrated pulmonary products whose success depends on preserving RNA function throughout manufacturing, aerosolization, post-deposition barrier navigation, intracellular delivery, and disease-relevant pharmacodynamic activity.<\/jats:p>","DOI":"10.3390\/pharmaceutics18080918","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:11:56Z","timestamp":1785168716000},"page":"918","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Target-Product and Translational Design Principles for Inhalable RNA Nanomedicines"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-8729","authenticated-orcid":false,"given":"Hossein","family":"Omidian","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5052-7947","authenticated-orcid":false,"given":"Sumana","family":"Dey Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-6342","authenticated-orcid":false,"given":"Luigi X.","family":"Cubeddu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/acsnano.3c08660","article-title":"Inhalable Bottlebrush Polymer Bioconjugates as Vectors for Efficient Pulmonary Delivery of Oligonucleotides","volume":"18","author":"Fang","year":"2023","journal-title":"ACS Nano"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"114601","DOI":"10.1016\/j.jconrel.2026.114601","article-title":"An inhalable liquid-core lipid nanoplatform enables macrophage-mediated mRNA delivery to lung tumors","volume":"391","author":"Liu","year":"2026","journal-title":"J. Control. Release"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"114607","DOI":"10.1016\/j.jconrel.2026.114607","article-title":"Optimized lipid nanoparticles for pulmonary delivery of CRISPR\/Cas9 targeting KRAS G12S in lung cancer","volume":"391","author":"Marschhofer","year":"2026","journal-title":"J. Control. Release"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"eabq0603","DOI":"10.1126\/scitranslmed.abq0603","article-title":"Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination","volume":"15","author":"Suberi","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11095-008-9755-4","article-title":"Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug","volume":"26","author":"Garbuzenko","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/nl5048972","article-title":"Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature","volume":"15","author":"Khan","year":"2015","journal-title":"Nano Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2511483123","DOI":"10.1073\/pnas.2511483123","article-title":"Lipid nanoparticle GM-CSF replacement for autoimmune pulmonary alveolar proteinosis","volume":"123","author":"Lian","year":"2026","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106370","DOI":"10.1016\/j.ejps.2023.106370","article-title":"Lipid nanoparticle-mediated mRNA delivery in lung fibrosis","volume":"183","author":"Massaro","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e2304966120","DOI":"10.1073\/pnas.2304966120","article-title":"Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection","volume":"120","author":"Tang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100200","DOI":"10.1016\/j.crbiot.2024.100200","article-title":"Nanocarriers for inhaled delivery of RNA therapeutics","volume":"7","author":"Huayamares","year":"2024","journal-title":"Curr. Res. Biotechnol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104076","DOI":"10.1016\/j.xphs.2025.104076","article-title":"Dry powder inhalation of siRNA therapeutics: Emerging strategies for pulmonary gene silencing","volume":"115","author":"Lu","year":"2026","journal-title":"J. Pharm. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107182","DOI":"10.1016\/j.ejps.2025.107182","article-title":"The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary delivery","volume":"212","author":"Rademacker","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"114986","DOI":"10.1016\/j.jconrel.2026.114986","article-title":"Aerosol flow-driven instability and droplet-interfacial stabilization of mRNA lipid nanoparticles during mesh nebulization","volume":"395","author":"Jeong","year":"2026","journal-title":"J. Control. Release"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"123050","DOI":"10.1016\/j.ijpharm.2023.123050","article-title":"Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA","volume":"640","author":"Miao","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Guan, S., Darmst\u00e4dter, M., Xu, C.F., and Rosenecker, J. (2021). In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment. Pharmaceutics, 13.","DOI":"10.21203\/rs.3.rs-133486\/v2"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2421915122","DOI":"10.1073\/pnas.2421915122","article-title":"Inhaled DNAI1 mRNA therapy for treatment of primary ciliary","volume":"122","author":"Hennig","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Deng, X., Yang, Y.J., Gan, L.M., Duan, X.L., Wang, X.W., Zhang, J.Y., Wang, A.P., Zhang, A.A., Yuan, Z.Z., and Chen, D.Q. (2025). Engineering Lipid Nanoparticles to Enhance Intracellular Delivery of Transforming Growth Factor-Beta siRNA (siTGF-\u03b21) via Inhalation for Improving Pulmonary Fibrosis Post-Bleomycin Challenge. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17020157"},{"key":"ref_21","first-page":"1765","article-title":"Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis","volume":"14","author":"Ding","year":"2018","journal-title":"Nanomed.-Nanotechnol. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.05.261","article-title":"Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension","volume":"210","author":"McLendon","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2019.10.030","article-title":"Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes","volume":"314","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1021\/acs.biomac.7b00572","article-title":"Anti-Inflammatory Effect of Anti-TNF-\u03b1 SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model","volume":"18","author":"Bohr","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"124960","DOI":"10.1016\/j.ijpharm.2024.124960","article-title":"Neutrophil membrane-coated nanoparticles for targeted delivery of toll-like receptor 4 siRNA ameliorate LPS-induced acute lung injury","volume":"668","author":"Cao","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1021\/acsami.1c14975","article-title":"Hybrid Lipid\/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?","volume":"14","author":"Conte","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2023.01.014","article-title":"Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma","volume":"354","author":"Kandil","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1111\/all.14850","article-title":"Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation","volume":"76","author":"Khaitov","year":"2021","journal-title":"Allergy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1186\/s12967-024-05711-9","article-title":"Innovative nebulization delivery of lipid nanoparticle-encapsulated siRNA: A therapeutic advance for Staphylococcus aureus-induced pneumonia","volume":"22","author":"Meng","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/mt.2013.10","article-title":"Enhanced Intrapulmonary Delivery of Anticancer siRNA for Lung Cancer Therapy Using Cationic Ethylphosphocholine-based Nanolipoplexes","volume":"21","author":"Shim","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cclet.2016.12.013","article-title":"Anti-tumor effects of combined doxorubicin and siRNA for pulmonary delivery","volume":"28","author":"Xu","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1038\/s41467-025-63415-0","article-title":"Modulating tumor collagen fiber alignment for enhanced lung cancer immunotherapy via inhaled RNA","volume":"16","author":"Hu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"121539","DOI":"10.1016\/j.biomaterials.2022.121539","article-title":"Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growth","volume":"285","author":"Ma","year":"2022","journal-title":"Biomaterials"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0885328219863291","article-title":"Mucopenetrating lipoplexes modified with PEG and hyaluronic acid for CD44-targeted local siRNA delivery to the lungs","volume":"34","author":"Almeida","year":"2019","journal-title":"J. Biomater. Appl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/jamp.2017.1364","article-title":"Hybrid Lipid\/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier","volume":"31","author":"Costabile","year":"2018","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/10717544.2018.1440668","article-title":"Water-soluble substituted chitosan derivatives as technology platform for inhalation delivery of siRNA","volume":"25","author":"Capel","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1089\/jamp.2013.1045","article-title":"Early-Stage Development of Novel Cyclodextrin-siRNA Nanocomplexes Allows for Successful Postnebulization Transfection of Bronchial Epithelial Cells","volume":"27","author":"Hibbitts","year":"2014","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.1021\/acsnano.0c04489","article-title":"Surfactant Protein B Promotes Cytosolic SiRNA Delivery by Adopting a Virus-like Mechanism of Action","volume":"15","author":"Guagliardo","year":"2021","journal-title":"ACS Nano"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","article-title":"Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.actbio.2018.08.012","article-title":"Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy","volume":"78","author":"Merckx","year":"2018","journal-title":"Acta Biomater."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.actbio.2025.08.032","article-title":"Sulfonium lipid nanoparticles for intranasal mRNA delivery to lung epithelial and immune cells","volume":"205","author":"Men","year":"2025","journal-title":"Acta Biomater."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1021\/acsami.1c23069","article-title":"Surface Coating of Pulmonary siRNA Delivery Vectors Enabling Mucus Penetration, Cell Targeting, and Intracellular Radical Scavenging for Enhanced Acute Lung Injury Therapy","volume":"14","author":"Zhu","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsnano.4c13053","article-title":"Nebulized Lipid Nanoparticles Based on Degradable Ionizable Glycerolipid for Potent Pulmonary mRNA Delivery","volume":"19","author":"Huang","year":"2025","journal-title":"ACS Nano"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, H.R., Leal, J., Soto, M.R., Smyth, H.D.C., and Ghosh, D. (2020). Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111042"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"114266","DOI":"10.1016\/j.ejpb.2024.114266","article-title":"Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route","volume":"198","author":"Ongun","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2217\/nnm.12.203","article-title":"The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels","volume":"8","author":"Braeckmans","year":"2013","journal-title":"Nanomedicine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2010.12.017","article-title":"Comparative in vivo study of poly(ethylene imine)\/siRNA complexes for pulmonary delivery in mice","volume":"151","author":"Beyerle","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2219870","DOI":"10.1080\/10717544.2023.2219870","article-title":"PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA","volume":"30","author":"Xu","year":"2023","journal-title":"Drug Deliv."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2017.05.046","article-title":"TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations","volume":"527","author":"Bielski","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2017.07.013","article-title":"Inhaled powder formulation of naked siRNA using spray drying technology with L-leucine as dispersion enhancer","volume":"530","author":"Chow","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2400509","DOI":"10.1002\/adhm.202400509","article-title":"Inhalable Dry Powders for Lung mRNA Delivery","volume":"13","author":"Gordon","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"120215","DOI":"10.1016\/j.ijpharm.2021.120215","article-title":"Aerosolizable siRNA-encapsulated solid lipid nanoparticles prepared by thin-film freeze-drying for potential pulmonary delivery","volume":"596","author":"Wang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Jansen, E.M., Ruigrok, M.J.R., Suh, M.S., Ruppel, P.M., Cui, X.L., Opsomer, L., Sanders, N.N., Frijlink, H.W., and Hinrichs, W.L.J. (2026). Freeze-Drying in Sucrose Followed by Cryomilling Enables the Formulation of sa-mRNA-LNP Powders for Inhalation. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18010121"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"114749","DOI":"10.1016\/j.jconrel.2026.114749","article-title":"A functional lyoprotectant platform enables storage-stable, mucus-penetrating siRNA delivery to the lung","volume":"393","author":"Sun","year":"2026","journal-title":"J. Control. Release"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"107383","DOI":"10.1016\/j.ejps.2025.107383","article-title":"Impact of formulation and process parameters on the stability and bioactivity of RNA-loaded lipid nanoparticles during nebulization","volume":"216","author":"Wiebe","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"107300","DOI":"10.1016\/j.ejps.2025.107300","article-title":"Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols","volume":"214","author":"Biesel","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"107651","DOI":"10.1016\/j.jddst.2025.107651","article-title":"Rayleigh-based soft mist inhalers preserve mRNA-LNP integrity for pulmonary delivery","volume":"115","author":"He","year":"2026","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"18507","DOI":"10.1038\/s41598-025-03309-9","article-title":"Laminar fluid ejection device enables high yield and preservation of mRNA and SaRNA LNP formulations","volume":"15","author":"Ho","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1021\/acsnano.4c00768","article-title":"Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation","volume":"18","author":"Kim","year":"2024","journal-title":"ACS Nano"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"107386","DOI":"10.1016\/j.ejps.2025.107386","article-title":"Pulmonary delivery of siRNA lipoplexes and lipid nanoparticles using a vibrating mesh nebuliser","volume":"216","author":"Neary","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"62647","DOI":"10.1021\/acsami.5c18977","article-title":"Smart Inhalation Therapy: Boosting siRNA Efficacy with Inulin-Based Multifunctional Polymers","volume":"17","author":"Drago","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","volume":"351","author":"Zimmermann","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1039\/D5BM01911G","article-title":"Inflammation-responsive hierarchical delivery of anti-inflammatory siRNA and peptide alleviates cytokine storm in pneumonia","volume":"14","author":"Li","year":"2026","journal-title":"Biomater. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"114570","DOI":"10.1016\/j.jconrel.2025.114570","article-title":"Inhalable perfluorocarbon RNA nanocapsules overcome biological barriers to treat lung metastases","volume":"391","author":"Siddhanta","year":"2026","journal-title":"J. Control. Release"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1021\/acs.molpharmaceut.7b00725","article-title":"From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery","volume":"14","author":"Qiu","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/acs.biomac.5b01646","article-title":"Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections","volume":"17","author":"Perfetto","year":"2016","journal-title":"Biomacromolecules"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1021\/acsami.0c21259","article-title":"Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration","volume":"13","author":"Wu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1805116","DOI":"10.1002\/adma.201805116","article-title":"Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium","volume":"31","author":"Patel","year":"2019","journal-title":"Adv. Mater."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biomaterials.2016.12.001","article-title":"Aerosol delivery of stabilized polyester-siRNA nanoparticles to silence gene expression in orthotopic lung tumors","volume":"118","author":"Yan","year":"2017","journal-title":"Biomaterials"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"0107","DOI":"10.34133\/bmr.0107","article-title":"Pulmonary Delivery of Anti-microRNA Oligonucleotide and Glycyrrhizic Acid Using Ternary Peptide Micelles for the Treatment of Acute Lung Injury","volume":"28","author":"Kang","year":"2024","journal-title":"Biomater. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"54344","DOI":"10.1021\/acsami.4c04241","article-title":"siRNA Nanoparticle Dry Powder Formulation with High Transfection Efficiency and Pulmonary Deposition for Acute Lung Injury Treatment","volume":"16","author":"Xu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","article-title":"Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2414991","DOI":"10.1002\/adma.202414991","article-title":"Highly Branched Poly(\u03b2-amino ester)s for Efficient mRNA Delivery and Nebulization Treatment of Silicosis","volume":"37","author":"Yong","year":"2025","journal-title":"Adv. Mater."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"eadt2752","DOI":"10.1126\/sciadv.adt2752","article-title":"Hydrogen-induced disruption of the airway mucus barrier enhances nebulized RNA delivery to reverse pulmonary fibrosis","volume":"11","author":"Liu","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Haettig, E., Haben, A., Kautenburger, R., and Schneider, M. (2026). Delivery of siRNA and Chloroquine Through an Aspherical, Nanostructured Microparticle for Passive Targeting of Alveolar Macrophages and Inhibition of Local TNF-\u03b1 Secretion. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18020154"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Hibbitts, A.J., Ramsey, J.M., Barlow, J., MacLoughlin, R., and Cryan, S.A. (2020). In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8\/CxCL-1 siRNA Delivery to the Lungs. Nanomaterials, 10.","DOI":"10.3390\/nano10071248"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Nguyen, D.B.T., Ali, A.S.M., Wu, D.W., Berg, J., Lauster, D.C., Kurreck, J., and Tolksdorf, B. (2026). Functional siRNA Delivery via Jet Nebulization: Proof-of-Concept IL-1\u00df Silencing in Macrophage-like THP-1 Cells. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27062915"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"119338","DOI":"10.1016\/j.ijpharm.2020.119338","article-title":"Developing spray-freeze-dried particles containing a hyaluronic acid-coated liposome-protamine-DNA complex for pulmonary inhalation","volume":"583","author":"Fukushige","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1073\/pnas.1004604107","article-title":"Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance","volume":"107","author":"Garbuzenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11095-022-03443-3","article-title":"Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery","volume":"41","author":"Baldassi","year":"2024","journal-title":"Pharm. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/acs.biomac.4c00387","article-title":"Diving into RNAi Therapy: An Inhalable Formulation Based on Lipid-Polymer Hybrid Systems for Pulmonary Delivery of siRNA","volume":"26","author":"Cabibbo","year":"2024","journal-title":"Biomacromolecules"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1039\/D4NA01034E","article-title":"RNA lipid nanoparticles stabilized during nebulization through excipient selection","volume":"7","author":"Slaughter","year":"2025","journal-title":"Nanoscale Adv."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s13346-023-01402-y","article-title":"Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery","volume":"14","author":"Sarode","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejpb.2020.08.009","article-title":"Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-\u03b1 siRNA with PAMAM dendrimers in a murine model","volume":"156","author":"Bohr","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1021\/mp500473d","article-title":"Therapeutic Aerosol Bioengineering of siRNA for the Treatment of Inflammatory Lung Disease by TNF\u03b1 Gene Silencing in Macrophages","volume":"11","author":"Kelly","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2100073","DOI":"10.1002\/adtp.202100073","article-title":"Impact of Crystalline and Amorphous Matrices on Successful Spray Drying of siRNA Polyplexes for Inhalation of Nano-in-Microparticles","volume":"4","author":"Keil","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.03.029","article-title":"Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma","volume":"229","author":"Xie","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"125335","DOI":"10.1016\/j.ijpharm.2025.125335","article-title":"Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technology","volume":"672","author":"Li","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/1061186X.2016.1278219","article-title":"Nebulized anionic guanidinylated O-carboxymethyl chitosan\/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: Preparation, characterization and in vitro evaluation","volume":"25","author":"Ni","year":"2017","journal-title":"J. Drug Target."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2008.06.010","article-title":"Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy","volume":"132","author":"Nguyen","year":"2008","journal-title":"J. Control. Release"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1007\/s11095-010-0255-y","article-title":"Pulmonary Gene Silencing in Transgenic EGFP Mice Using Aerosolised Chitosan\/siRNA Nanoparticles","volume":"27","author":"Nielsen","year":"2010","journal-title":"Pharm. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejpb.2012.04.022","article-title":"Pulmonary delivery and tissue distribution of aerosolized antisense 2\u2032-O-Methyl RNA containing nanoplexes in the isolated perfused and ventilated rat lung","volume":"81","author":"Dong","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"104301","DOI":"10.1016\/j.xphs.2026.104301","article-title":"Probing surfactant protein B fragments as endogenous RNA carriers for pulmonary delivery","volume":"115","author":"Chow","year":"2026","journal-title":"J. Pharm. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"126104","DOI":"10.1016\/j.ijpharm.2025.126104","article-title":"Development of aerosolizable mRNA incorporated chitosan nanoparticles for efficient lung delivery","volume":"684","author":"Kota","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1021\/acs.molpharmaceut.0c01242","article-title":"Optimization of PEGylated KL4 Peptide for siRNA Delivery with Improved Pulmonary Tolerance","volume":"18","author":"Qiu","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpb.2011.08.008","article-title":"Factors influencing polycation\/siRNA colloidal stability toward aerosol lung delivery","volume":"80","author":"Steele","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"118818","DOI":"10.1016\/j.ijpharm.2019.118818","article-title":"High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin","volume":"572","author":"Chow","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Johler, S.M., Rejman, J., Guan, S., and Rosenecker, J. (2015). Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137504"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"24204","DOI":"10.1021\/acsnano.4c05653","article-title":"Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration","volume":"18","author":"Jang","year":"2024","journal-title":"ACS Nano"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e10580","DOI":"10.1002\/btm2.10580","article-title":"Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles","volume":"8","author":"Lewis","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"174966","DOI":"10.1016\/j.cej.2026.174966","article-title":"Regio-divergent strategy inspired construction of ionizable lipidoids enable high performance in mRNA delivery","volume":"533","author":"Wang","year":"2026","journal-title":"Chem. Eng. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41587-024-02490-y","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","volume":"43","author":"Witten","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12195-020-00619-y","article-title":"Naturally Derived Membrane Lipids Impact Nanoparticle-Based Messenger RNA Delivery","volume":"13","author":"Kim","year":"2020","journal-title":"Cell. Mol. Bioeng."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2011.08.011","article-title":"Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA","volume":"157","author":"Jensen","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2013.07.024","article-title":"Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery","volume":"455","author":"Sharma","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1021\/mp4006358","article-title":"Poly(amidoamine) Dendrimer Nanocarriers and Their Aerosol Formulations for siRNA Delivery to the Lung Epithelium","volume":"11","author":"Conti","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2019.10.026","article-title":"Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide","volume":"314","author":"Qiu","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejpb.2020.09.011","article-title":"Lyophilization and nebulization of pulmonary surfactant-coated nanogels for siRNA inhalation therapy","volume":"157","author":"Merckx","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"114223","DOI":"10.1016\/j.ejpb.2024.114223","article-title":"Evaluating 82-agonists as siRNA delivery adjuvants for pulmonary surfactant-coated nanogel inhalation therapy","volume":"197","author":"Merckx","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2019.05.019","article-title":"Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders","volume":"566","author":"Wu","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"124632","DOI":"10.1016\/j.ijpharm.2024.124632","article-title":"Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying","volume":"665","author":"Ogawa","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"121758","DOI":"10.1016\/j.ijpharm.2022.121758","article-title":"Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles","volume":"621","author":"Xu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Xu, Y., Turan, E.T., Shi, Z.N., Franzyk, H., Thakur, A., and Foged, C. (2022). Inhalable Composite Microparticles Containing siRNA-Loaded Lipid-Polymer Hybrid Nanoparticles: Saccharides and Leucine Preserve Aerosol Performance and Long-Term Physical Stability. Front. Drug Deliv., 2.","DOI":"10.3389\/fddev.2022.945459"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"106088","DOI":"10.1016\/j.ultsonch.2022.106088","article-title":"Nebulization of siRNA for inhalation therapy based on a microfluidic surface acoustic wave platform","volume":"88","author":"Masoumi","year":"2022","journal-title":"Ultrason. Sonochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","article-title":"Combinatorial development of nebulized mRNA delivery formulations for the lungs","volume":"19","author":"Jiang","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jamp.2011-0966","article-title":"Characterization and Application of a Nose-Only Exposure Chamber for Inhalation Delivery of Liposomal Drugs and Nucleic Acids to Mice","volume":"26","author":"Mainelis","year":"2013","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.carbpol.2017.09.075","article-title":"GABAB receptor ligand-directed trimethyl chitosan\/tripolyphosphate nanoparticles and their pMDI formulation for survivin siRNA pulmonary delivery","volume":"179","author":"Ni","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1038\/s41467-025-59136-z","article-title":"Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing","volume":"16","author":"Vlasova","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pupt.2010.03.007","article-title":"RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice","volume":"23","author":"Gutbier","year":"2010","journal-title":"Pulm. Pharmacol. Ther."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:14:53Z","timestamp":1785168893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/8\/918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":119,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pharmaceutics18080918"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18080918","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}